Showing 61 - 80 results of 516 for search '"angiogenesis inhibitor"', query time: 0.21s Refine Results
  1. 61
  2. 62

    Pharmacokinetics of gene recombined angiogenesis inhibitor Kringle 5 in vivo using 131I specific markers and SPECT/CT by Ge Yan, Danrong Yang, Yan Yu, Jianjun Xue, Yifan Jia, Xuanzi Sun, Boyu Wang, Zewei Zhao, Maode Wang

    Published 2016-10-01
    “…Labeling recombinant angiogenesis inhibitor Kringle 5 using 131I with longer half-life and imaging in vivo using SPECT instead of PET, could overcome the limitations of previous methods. …”
    Get full text
    Article
  3. 63

    First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for -altered NSCLC: a retrospective real-world POLISH study by Guangjian Yang, Yaning Yang, Runze Liu, Weihua Li, Haiyan Xu, Xuezhi Hao, Junling Li, Puyuan Xing, Shuyang Zhang, Xin Ai, Fei Xu, Yan Wang

    Published 2022-03-01
    “…Accordingly, our retrospective, real-world POLISH study assesses the efficacy of first-line chemotherapy alone (C) as well as combinations with immune checkpoint inhibitors (C + I) or angiogenesis inhibitors (C + A) for HER2 -altered NSCLC; molecular features are also reported. …”
    Get full text
    Article
  4. 64

    Research Progress of Angiogenesis Inhibitors Plus EGFR-TKI in EGFR-mutated 
Advanced Non-small Cell Lung Cancer by Bowen LI, Jianchao XUE, Yadong WANG, Zhicheng HUANG, Naixin LIANG, Shanqing LI

    Published 2022-08-01
    “…EGFR-TKI combined with angiogenesis inhibitors is a treatment scheme being explored to delay the therapeutic resistance, which is called “A+T treatment”. …”
    Get full text
    Article
  5. 65

    Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1. by Hiroki Miyashita, Tatsuaki Watanabe, Hideki Hayashi, Yasuhiro Suzuki, Takanobu Nakamura, Soichi Ito, Manabu Ono, Yasushi Hoshikawa, Yoshinori Okada, Takashi Kondo, Yasufumi Sato

    Published 2012-01-01
    “…Vasohibin-1 (VASH1) is isolated as an endothelial cell (EC)-produced angiogenesis inhibitor. We questioned whether VASH1 plays any role besides angiogenesis inhibition, knocked-down or overexpressed VASH1 in ECs, and examined the changes of EC property. …”
    Get full text
    Article
  6. 66

    Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma by Hiroki Hagimoto, Soki Kashima, Kazuki Doi, Shintaro Nakayama, Takanori Sano, Satoshi Imai, Tomihiko Yasufuku, Mototsugu Muramaki, Yuji Yamada

    Published 2020-11-01
    “…The patient underwent nephrectomy and sequential therapy with interferon‐α and angiogenesis inhibitors. Lung metastasis decreased by angiogenesis inhibitors, but new right adrenal gland metastasis appeared. …”
    Get full text
    Article
  7. 67
  8. 68
  9. 69
  10. 70

    Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1.1 and angiostatin (K1-3). by Carolyn J MacMillan, Carolyn D Doucette, Jordan Warford, Suzanne J Furlong, David W Hoskin, Alexander S Easton

    Published 2014-01-01
    “…We conclude that these angiogenesis inhibitors mitigate EAE by both suppressing spinal cord angiogenesis and reducing peripheral T cell activation.…”
    Get full text
    Article
  11. 71
  12. 72

    Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study by Zengjun Liu, Jing Xu, Mengyao Liu, Wenyu Hu, Ni Xu, Dongyuan Zhu

    Published 2023-02-01
    “…Abstract Angiogenesis inhibitors (AIs) and immune checkpoint inhibitors (ICIs) are new treatment options for advanced soft tissue sarcoma (STS) patients. …”
    Get full text
    Article
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80